Saturday, 12 December 2015

Troubled Anesthesia Drug Problem, Managing Director of Kalbe Convey Company

Withdrawal of two products made drugs Kalbe Farma led to various speculations. Moreover, the withdrawal is done following two cases patients died at Siloam Hospital Karawaci, Tangerang after being given one of the recalled products, namely Buvanest Spinal anesthesia. Food and Drug Monitoring Agency (BPOM) suspected drug content swapped. Spinal Buvanes injected in the patient should contain Bupivacaine 0.5 percent, but in fact it contains acid that serves as a thickener Tranexamat blood. Told reporters, President Director of PT Kalbe Farma Irawati Setiady was deeply concerned over the incident. It pulled the drug product allegedly problematic on February 12, 2015

as a preventive measure so that consumers are protected to the maximum. \”The products allegedly was Buvanest Spinal. This product is a product that is very specific and only used in hospitals by medical specialists and should be by prescription. So it is not sold freely,\” said Irawati, in a press conference at Hotel Acacia, Jl Kramat Raya, Central Jakarta, Tuesday (02/17/2015). Corporate Secretary of PT Kalbe Farma Vidjongtius confessed to the examination of samples of suspected drug problem. On a sample of one hospital found no discrepancy label, but the sample was not found to retain a similar problem.

BPOM together with the Ministry of Health is currently conducting an investigation into this case. The findings of the investigation results of the plan will be published in a press conference on Wednesday afternoon (18/02/2015), housed at the Ministry of Health.

Troubled Anesthesia Drug Problem, Managing Director of Kalbe Convey Company

No comments:

Post a Comment